Pfizer, Inc. (PFE): Price and Financial Metrics
Pfizer, Inc. (PFE)
Today's Latest Price: $33.75 USD
0.28 (-0.82%)
Updated Jul 8 6:40pm
Add PFE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PFE Stock Summary
- Pfizer Inc's market capitalization of $187,475,639,198 is ahead of 99.33% of US-listed equities.
- PFE's went public 34.54 years ago, making it older than 92.88% of listed US stocks we're tracking.
- The volatility of Pfizer Inc's share price is greater than that of merely 2.49% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Pfizer Inc, a group of peers worth examining would be NVS, MRK, CSCO, SAP, and XOM.
- Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to www.pfizer.com.
PFE Daily Price Range
PFE 52-Week Price Range
PFE Stock Price Chart Technical Analysis Charts
PFE Price/Volume Stats
| Current price | $33.75 | 52-week high | $44.10 |
| Prev. close | $34.03 | 52-week low | $27.88 |
| Day low | $33.57 | Volume | 23,013,801 |
| Day high | $34.37 | Avg. volume | 30,310,986 |
| 50-day MA | $35.79 | Dividend yield | 4.5% |
| 200-day MA | $36.36 | Market Cap | 187.48B |
Pfizer, Inc. (PFE) Company Bio
Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.
Loading social stream, please wait...